Loading...
Loading...
Loading...
Loading...
No reviews have been added for this product.
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | PE |
| Immunogen | HPV16 E7 |
| Peptide Sequence | YMLDLQPETT |
| Class | Class I |
| Sequence Location | 11-20 |
| MHC Allele | A*02:01 |
| Documents & Links for HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE | |
| Datasheet | HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE Datasheet |
| Documents & Links for HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE | |
| Datasheet | HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE Datasheet |
| Citations for HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE – 1 Found |
| Quayle, Steven N; Girgis, Natasha; Thapa, Dharma R; Merazga, Zohra; Kemp, Melissa M; Histed, Alex; Zhao, Fan; Moreta, Miguel; Ruthardt, Paige; Hulot, Sandrine; Nelson, Alyssa; Kraemer, Lauren D; Beal, Dominic R; Witt, Luke; Ryabin, Jessica; Soriano, Jonathan; Haydock, Mark; Spaulding, Emily; Ross, John F; Kiener, Peter A; Almo, Steven; Chaparro, Rodolfo; Seidel, Ronald; Suri, Anish; Cemerski, Saso; Pienta, Kenneth J; Simcox, Mary Ellen. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2020;26(8):1953-1964. PubMed |
MBL Life Sciences
| Product Specifications | |
| Application | FC |
| Reactivity | Human |
| Conjugation | PE |
| Immunogen | HPV16 E7 |
| Peptide Sequence | YMLDLQPETT |
| Class | Class I |
| Sequence Location | 11-20 |
| MHC Allele | A*02:01 |
| Documents & Links for HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE | |
| Datasheet | HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE Datasheet |
| Documents & Links for HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE | |
| Datasheet | HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE Datasheet |
| Citations for HLA-A*02:01 HPV16 E7 Tetramer-YMLDLQPETT-PE – 1 Found |
| Quayle, Steven N; Girgis, Natasha; Thapa, Dharma R; Merazga, Zohra; Kemp, Melissa M; Histed, Alex; Zhao, Fan; Moreta, Miguel; Ruthardt, Paige; Hulot, Sandrine; Nelson, Alyssa; Kraemer, Lauren D; Beal, Dominic R; Witt, Luke; Ryabin, Jessica; Soriano, Jonathan; Haydock, Mark; Spaulding, Emily; Ross, John F; Kiener, Peter A; Almo, Steven; Chaparro, Rodolfo; Seidel, Ronald; Suri, Anish; Cemerski, Saso; Pienta, Kenneth J; Simcox, Mary Ellen. CUE-101, a Novel E7-pHLA-IL2-Fc Fusion Protein, Enhances Tumor Antigen-Specific T-Cell Activation for the Treatment of HPV16-Driven Malignancies. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research. 2020;26(8):1953-1964. PubMed |
